These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19694792)

  • 21. Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans.
    Cropley VL; Innis RB; Nathan PJ; Brown AK; Sangare JL; Lerner A; Ryu YH; Sprague KE; Pike VW; Fujita M
    Synapse; 2008 Jun; 62(6):399-408. PubMed ID: 18361438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo affinity of [18F]fallypride for striatal and extrastriatal dopamine D2 receptors in nonhuman primates.
    Slifstein M; Hwang DR; Huang Y; Guo N; Sudo Y; Narendran R; Talbot P; Laruelle M
    Psychopharmacology (Berl); 2004 Sep; 175(3):274-86. PubMed ID: 15024551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of low striatal dopamine d2 receptor availability with nicotine dependence similar to that seen with other drugs of abuse.
    Fehr C; Yakushev I; Hohmann N; Buchholz HG; Landvogt C; Deckers H; Eberhardt A; Kläger M; Smolka MN; Scheurich A; Dielentheis T; Schmidt LG; Rösch F; Bartenstein P; Gründer G; Schreckenberger M
    Am J Psychiatry; 2008 Apr; 165(4):507-14. PubMed ID: 18316420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol.
    Kessler RM; Ansari MS; Riccardi P; Li R; Jayathilake K; Dawant B; Meltzer HY
    Neuropsychopharmacology; 2005 Dec; 30(12):2283-9. PubMed ID: 16123775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine D
    Khodaii J; Nomura Y; Chang NHS; Wong DF; Møller A; Gjedde A
    Neurochem Res; 2023 May; 48(5):1517-1530. PubMed ID: 36525123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-affinity dopamine D2/D3 PET radioligands 18F-fallypride and 11C-FLB457: a comparison of kinetics in extrastriatal regions using a multiple-injection protocol.
    Vandehey NT; Moirano JM; Converse AK; Holden JE; Mukherjee J; Murali D; Nickles RJ; Davidson RJ; Schneider ML; Christian BT
    J Cereb Blood Flow Metab; 2010 May; 30(5):994-1007. PubMed ID: 20040928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. α2-adrenergic drugs modulate the binding of [18F]fallypride to dopamine D2/3 receptors in striatum of living mouse.
    Rominger A; Mille E; Böning G; Wängler B; Josef Gildehaus F; Arszol C; Bartenstein P; Cumming P
    Synapse; 2010 Aug; 64(8):654-7. PubMed ID: 20336625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measuring dopamine neuromodulation in the thalamus: using [F-18]fallypride PET to study dopamine release during a spatial attention task.
    Christian BT; Lehrer DS; Shi B; Narayanan TK; Strohmeyer PS; Buchsbaum MS; Mantil JC
    Neuroimage; 2006 May; 31(1):139-52. PubMed ID: 16469510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [
    Stark AJ; Smith CT; Petersen KJ; Trujillo P; van Wouwe NC; Donahue MJ; Kessler RM; Deutch AY; Zald DH; Claassen DO
    Neuroimage Clin; 2018; 18():433-442. PubMed ID: 29541577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia.
    Buchsbaum MS; Christian BT; Lehrer DS; Narayanan TK; Shi B; Mantil J; Kemether E; Oakes TR; Mukherjee J
    Schizophr Res; 2006 Jul; 85(1-3):232-44. PubMed ID: 16713185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Striatal and extrastriatal dopamine release measured with PET and [(18)F] fallypride.
    Slifstein M; Kegeles LS; Xu X; Thompson JL; Urban N; Castrillon J; Hackett E; Bae SA; Laruelle M; Abi-Dargham A
    Synapse; 2010 May; 64(5):350-62. PubMed ID: 20029833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride.
    Kegeles LS; Slifstein M; Frankle WG; Xu X; Hackett E; Bae SA; Gonzales R; Kim JH; Alvarez B; Gil R; Laruelle M; Abi-Dargham A
    Neuropsychopharmacology; 2008 Dec; 33(13):3111-25. PubMed ID: 18418366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [123I]Epidepride neuroimaging of dopamine D2/D3 receptor in chronic MK-801-induced rat schizophrenia model.
    Huang YR; Shih JM; Chang KW; Huang C; Wu YL; Chen CC
    Nucl Med Biol; 2012 Aug; 39(6):826-32. PubMed ID: 22464847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spinal cord dopamine D2/D3 receptors: in vivo and ex vivo imaging in the rat using (18)F/(11)C-fallypride.
    Kaur J; Khararjian A; Coleman RA; Constantinescu CC; Pan ML; Mukherjee J
    Nucl Med Biol; 2014; 41(10):841-7. PubMed ID: 25199843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PET studies of D2-receptor binding in striatal and extrastriatal brain regions: Biochemical support in vivo for separate dopaminergic systems in humans.
    Cervenka S; Varrone A; Fransén E; Halldin C; Farde L
    Synapse; 2010 Jun; 64(6):478-85. PubMed ID: 20175222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates.
    Innis RB; Malison RT; al-Tikriti M; Hoffer PB; Sybirska EH; Seibyl JP; Zoghbi SS; Baldwin RM; Laruelle M; Smith EO
    Synapse; 1992 Mar; 10(3):177-84. PubMed ID: 1532675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence.
    Ballard ME; Mandelkern MA; Monterosso JR; Hsu E; Robertson CL; Ishibashi K; Dean AC; London ED
    Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyu119. PubMed ID: 25603861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parametric mapping of binding in human brain of D2 receptor ligands of different affinities.
    Siessmeier T; Zhou Y; Buchholz HG; Landvogt C; Vernaleken I; Piel M; Schirrmacher R; Rösch F; Schreckenberger M; Wong DF; Cumming P; Gründer G; Bartenstein P
    J Nucl Med; 2005 Jun; 46(6):964-72. PubMed ID: 15937307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride.
    Narendran R; Frankle WG; Mason NS; Rabiner EA; Gunn RN; Searle GE; Vora S; Litschge M; Kendro S; Cooper TB; Mathis CA; Laruelle M
    Synapse; 2009 Jun; 63(6):447-61. PubMed ID: 19217025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic imaging of striatal D2 receptors in mice using quad-HIDAC PET.
    Honer M; Brühlmeier M; Missimer J; Schubiger AP; Ametamey SM
    J Nucl Med; 2004 Mar; 45(3):464-70. PubMed ID: 15001689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.